Raymond James Financial Services Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$126K Buy
+10,529
New +$91K ﹤0.01% 3256
2023
Q4
Sell
-31,770
Closed -$105K 3320
2023
Q3
$105K Sell
31,770
-324
-1% -$1.14K ﹤0.01% 3055
2023
Q2
$92.8K Sell
32,094
-1,298
-4% -$2.49K ﹤0.01% 3072
2023
Q1
$35.7K Sell
33,392
-1,301
-4% -$2.49K ﹤0.01% 3149
2022
Q4
$90.5K Sell
34,693
-8,723
-20% -$38.1K ﹤0.01% 3023
2022
Q3
$304K Buy
43,416
+4,433
+11% +$34.7K ﹤0.01% 2563
2022
Q2
$266K Sell
38,983
-227
-0.6% -$2.32K ﹤0.01% 2675
2022
Q1
$553K Sell
39,210
-422
-1% -$5.65K ﹤0.01% 2322
2021
Q4
$574K Buy
+39,632
New +$563K ﹤0.01% 2306

Other funds holding BVS

Raymond James Financial Services Advisors's BVS Position: Q3 2024 in Review

Raymond James Financial Services Advisors opened a new position in Bioventus (BVS) in Q3 2024: 10,529 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #3256 among its holdings. This is a return to the name: Raymond James Financial Services Advisors previously reported a position in BVS as recently as Q3 2023.

Raymond James Financial Services Advisors first reported a position in BVS in Q4 2021 and has held it in 9 quarters since. The position peaked at $574K in Q4 2021. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • Raymond James Financial Services Advisors held 10,529 shares of Bioventus worth $126K as of Q3 2024.
  • Bioventus was a new Raymond James Financial Services Advisors position in Q3 2024.
  • Bioventus made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3256 holding.
  • Raymond James Financial Services Advisors first reported a position in Bioventus in Q4 2021 and has held it in 9 quarters since.
  • Raymond James Financial Services Advisors's Bioventus position peaked at $574K in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.